Ably Medical, a Norwegian startup founded in 2015, focuses on addressing nursing shortages and improving patient care through innovative IoT solutions. The company's flagship product, LYNG, aims to empower healthcare staff and enhance patient care by seamlessly measuring vital signs such as heart rate, respiration, temperature, blood pressure, blood oxygen, and movement in various care settings, including hospital beds, nursing homes, and home care. The company's slogan, "Empowering caregivers, transforming hospitals," succinctly captures its mission to revolutionize the healthcare industry. Ably Medical operates within the Health Care and Medical Devices industries, positioning itself at the intersection of technology and healthcare. Ably Medical secured a significant kr32.00M Venture Round investment on 03 May 2018, demonstrating confidence from investors in the company's vision and potential for growth. The identity of the specific investors behind this funding round remains undisclosed, but the infusion of capital undoubtedly signifies external validation and support for Ably Medical's endeavors. In summary, Ably Medical's innovative approach to healthcare, coupled with its recent investment success, positions the company as a compelling player in the evolving landscape of medical technology and patient care. As the company continues to expand its offerings and solidify its presence in the market, its impact on addressing nursing shortages and enhancing patient care is poised to be increasingly significant.
No recent news or press coverage available for Ably Medical.